Molecular Genetics and Metabolism

Molecular Genetics and Metabolism is published by Academic Press Inc. and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lysosomal Storage Disorders Research, Metabolism and Genetic Disorders and Glycogen Storage Diseases and Myoclonus, together about 46.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Molecular Genetics and Metabolism is the official journal of the Society for Inherited Metabolic Disorders, dedicated to advancing the understanding of inborn metabolic diseases and metabolic dysfunction in Mendelian conditions, through innovative research in molecular genetics and metabolic pathways.The journal publishes high-quality original full-length research articles, short communications and reviews, studied in human patients, animal models, cellular systems, and computational frameworks. The journal does not consider case reports, which should be directed to the companion title, Molecular Genetics and Metabolism Reports.Molecular Genetics and Metabolism spans the fundamental, translational, and clinical research domains.The journal considers articles on the following topics:Fundamental mechanisms of inherited metabolic diseases:Studies on pathophysiology in inborn metabolic disease,Molecular mechanisms of enzyme function and dysfunction in metabolic processes,Mechanistic studies of disease at the cellular and biochemical levels,Investigations into mitochondrial function and its role in inherited metabolic disorders,Studies on cellular metabolism, including bioenergetics and metabolic flux,Genetic and epigenetic mechanisms influencing metabolic pathways,Crosstalk between metabolic pathways using multi-OMICS technologies, including proteomics, metabolomics, etc,Innovations in experimental techniques, such as gene editing,Study of metabolic dysfunction in congenital disorders,Bioinformatics and computational models.Translational and clinical investigations:Advances in metabolic engineering, gene therapy, and personalized medicine; evaluation of novel therapeutic approaches.Clinical trials and longitudinal studies assessing the outcomes of early intervention and treatment strategies.Novel methods in newborn screening and their validated results.Diagnosis of Inherited Metabolic Diseases, including validation of new diagnostic approaches.Definition of new phenotypes and description of novel genetic disordersPatient-centered research focusing on the management, quality of life and healthcare needs.Clinical guidelines and treatment protocols for IMDs.Studies primarily focused on acquired metabolic conditions, such as metabolic syndrome, obesity, lifestyle-associated metabolic disorders, non-inherited cancers, or other multifactorial metabolic diseases, are outside the scope of the journal.Authors are also welcome to submit to the journal's gold open access

From the journal's Aims & Scope

Research area (LetPub): Biochemistry & Molecular Biology

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

4LetPub · 2026-09-13

Impact factor (publisher)

4Publisher website · 2026-09-29

CiteScore 2026-06

6.2LetPub · 2026-09-13

CiteScore (publisher)

6.2Publisher website · 2026-09-29

SJR 2026-06

1.35LetPub · 2026-09-13

SNIP 2026-06

1.64LetPub · 2026-09-13

h-index

99LetPub · 2026-09-13

h-index

147OpenAlex · 2026-10-01

i10-index

3,711OpenAlex · 2026-10-01

2-year mean citedness

0.78OpenAlex · 2026-10-01

Self-citation rate

10%LetPub · 2026-09-13

Share of gold OA articles

38.69%LetPub · 2026-09-13

Volume

Articles per year

161LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

3–6 weeksLetPub · 2026-09-13

Average acceptance (community reports)

EasyLetPub · 2026-09-13

Submission to first decision

4 daysPublisher website · 2026-09-29

First decision after review

32 daysPublisher website · 2026-09-29

Submission to acceptance

82 daysPublisher website · 2026-09-29

Acceptance to publication

3 daysPublisher website · 2026-09-29

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Academic Press Inc.

Country or region

UNITED STATES

Language

English

Frequency

Monthly

Founded

1998

ISSN

1096-7192

Electronic ISSN

1096-7206

Society / sponsor

Society for Inherited Metabolic Disorders

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗Publisher website
• Special issues ↗Publisher website